CHARLOTTE, NC--(Marketwired - December 14, 2016) - DebMed's recent acquisition of STERIS hand hygiene and surface disinfectants (AIC) allows the company to introduce its full array of hand hygiene and skin care innovation to the U.S. hospitals, partnering with them to help staff achieve the highest standards of hand hygiene behavior.
This acquisition comes as the global infection control market is expected to reach $17.78 billion by 2021, according to a recent Research and Markets report, "Infection Control Market by Disinfection Products, Sterilization Products, End User - Global Forecast to 2021."
The report found that demand is primarily driven by growth in the number of surgical procedures, growing aging population, and rising incidents of hospital-associated infections (HAIs). A lack of hand hygiene compliance by healthcare staff continues to be a significant contributor to the spread of pathogens, resulting in HAIs and affecting hospital reputation and the risk of financial penalties.
"The addition of STERIS' hand hygiene and disinfectant portfolio enables DebMed to offer an integrated hand hygiene compliance and skin care program formulated specifically for the healthcare industry," said DebMed President Didier Bouton. "It also keeps pace with a growing demand for infection control solutions and helps the U.S. healthcare industry meet hand hygiene and infection prevention standards and guidelines."
Together the two companies offer more than a century of professional hand hygiene experience and can now provide a solution comprised of:
- Essential products for hand hygiene, patient skin antisepsis and hard surface disinfectants;
- Reliable vital information provided via electronic hand hygiene compliance data delivered in real time; and
- Best practice tools and resources based on the highest standards of behavior, including experienced field-based support staff.
DebMed's unique, integrated hand hygiene compliance and skin care program, now enhanced by the introduction of STERIS' hand hygiene and disinfectant portfolio, is customized to each
healthcare environment and proven to increase hand hygiene compliance and significantly reduce HAIs by 42%.
Additionally, the condition of healthcare staff hands can be a significant barrier to hand hygiene compliance with 1 in 7 US hospital staff members suffering from dermatitis, according to "Prevalence of Dermatitis in the Working Population, United States," a 2010 National Health Interview Survey by the American Journal of Industrial Medicine.
DebMed's essential hand hygiene and skin care products, including triclosan-alternative products, are developed specifically for healthcare and safe for frequent use to improve the skin health of hospital staff.
DebMed is the healthcare program of the Deb Group. The DebMed program offers innovative hand hygiene products, electronic monitoring technology, and improvement tools to support hand hygiene compliance. The DebMed® GMS™ (Group Monitoring System), winner of the 2013 Frost & Sullivan Hand Hygiene Solutions New Product Innovation Award, is the world's first group monitoring system to report hand hygiene compliance rates based on the World Health Organization's (WHO) "Five Moments for Hand Hygiene" and to date has recorded more than 80 million hand hygiene events. The system is being utilized in a four year, multi-site research project being conducted by the Columbia University School of Nursing and funded by a $1.2 million grant from the Agency for Healthcare Research and Quality (AHRQ). For more information, visit www.debmed.com.
Image Available: http://www.marketwire.com/library/MwGo/2016/12/14/11G125149/Images/DebMed_Hand_Hygiene_Monitoring-a777ad9a8d74ae54b7a604acc83c32cc.jpg